Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11

Trial Status

Completed1

Role Distribution

Other Roles1

Activity Timeline

Clinical Trials (1)

NCT04995653Phase 1Completed
A Multiple Dose Study to Evaluate Safety, Tolerability, PK, and Efficacy of SER-155 in Adults Undergoing HSCT
Allogeneic Hematopoietic Stem Cell Transplantation
StudydirectorStart date: 2021-11-24

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Seres Therapeutics, Inc.

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Stephanie Nguyen Quoc, Doctor

Assistance Publique - Hôpitaux de Paris

Moderately Similar
1 trials

Shared therapeutic areas:

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Similarity Score30%

Kirk R. Schultz, MD

University of British Columbia / BC Children's Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Similarity Score30%

Jingtao Huang

Ruijin Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Similarity Score30%

Stefan O. Ciurea, MD

Chao Family Comprehensive Cancer Center

Moderately Similar
1 trials

Shared therapeutic areas:

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Similarity Score30%

Xiaoyang Yang

Department of Hematology, Haikou People's Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Similarity Score30%

Suning Chen, professor

The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology

Moderately Similar
4 trials

Shared therapeutic areas:

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Similarity Score30%

Li Xuan, MD

Nanfang Hospital, Southern Medical University

Moderately Similar
3 trials

Shared therapeutic areas:

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Similarity Score30%

Jing Sun, MD

Department of Hematology, Nanfang Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Similarity Score30%

Lanping Xu, PhD,MD

Peking University People's Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Similarity Score30%

Linghui Xia, Professor

Department of Hematology, Wuhan Union Hospital, Tongji Medical college, Huazhong University of Science and Technology

Moderately Similar
1 trials

Shared therapeutic areas:

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT04995653Phase 1StudyDirector

A Multiple Dose Study to Evaluate Safety, Tolerability, PK, and Efficacy of SER-155 in Adults Undergoing HSCT

Allogeneic Hematopoietic Stem Cell Transplantation
Completed

All 1 trials loaded